Type 1B Diabetes Masquerading as Type 2 Diabetes in a Pediatric Patient: A Case Report

Technical Summary: Type 1B Diabetes Masquerading as Type 2 Diabetes in a Pediatric Patient

Problem Statement
Type 1B diabetes (idiopathic type 1 diabetes) is a rare form of the disease characterized by severe insulin deficiency in the absence of autoimmune markers. In pediatric populations, this condition is frequently misdiagnosed as Type 2 diabetes due to overlapping clinical presentations, such as hyperglycemia, or the presence of a family history of Type 2 diabetes. This misdiagnosis poses a significant clinical risk, as it can lead to delays in initiating insulin therapy, potentially resulting in severe complications like diabetic ketoacidosis (DKA). The core challenge lies in distinguishing seronegative Type 1B diabetes from Type 2 diabetes, particularly when patients present with atypical features such as severe hyperglycemia and underweight status despite a family history of Type 2 diabetes.

Methodology
This study employs a single-patient case report methodology to illustrate the diagnostic and therapeutic trajectory of an 11-year-old South Asian female. The methodology involves:

• Clinical Assessment: Evaluation of presenting symptoms (polyuria, polydipsia, weakness, weight loss), anthropometric data (BMI 14.8), and family history.
• Laboratory Investigation: Comprehensive screening including random blood sugar, HbA1c, urine ketones, complete blood count, and specific serological markers (GAD antibodies) and metabolic markers (C-peptide levels).
• Therapeutic Trial: The patient was initially treated with oral hypoglycemic agents for 10 days. Upon failure of this regimen, the treatment protocol was switched to insulin therapy.
• Follow-up: Clinical status and blood glucose levels were monitored one week after the initiation of insulin therapy.

Key Results

• Patient Profile: The patient presented with significant unintentional weight loss (5 kg in one month), severe hyperglycemia (random blood sugar 500 mg/dL), and a markedly elevated HbA1c (14%).
• Diagnostic Findings: Despite the severe hyperglycemia, urine ketones were negative. Crucially, GAD antibodies were negative, ruling out classic autoimmune Type 1A diabetes. C-peptide levels were within the normal range, which initially complicated the differentiation from Type 2 diabetes.
• Treatment Response: The initial 10-day trial of oral hypoglycemic agents resulted in no clinical improvement. Following the switch to insulin therapy, the patient experienced rapid symptom resolution. A one-week follow-up showed stabilized blood glucose levels (125 mg/dL) and improved clinical status.

Key Contributions
The paper contributes to the clinical understanding of pediatric diabetes by:

1. Highlighting Diagnostic Pitfalls: It documents a specific scenario where a child with a strong family history of Type 2 diabetes and negative autoimmune markers was initially mismanaged with oral agents, delaying appropriate insulin therapy.
2. Defining a Clinical Profile: It reinforces the profile of Type 1B diabetes in children: severe hyperglycemia, underweight status (low BMI), negative autoimmune markers, and a poor response to oral hypoglycemics.
3. Emphasizing Diagnostic Flexibility: The case demonstrates the necessity of maintaining a high index of suspicion for non-classical diabetes subtypes when standard diagnostic criteria (such as family history or BMI) do not align with the severity of the clinical presentation.

Significance and Claims
The authors assert that Type 1B diabetes is an underdiagnosed condition in pediatric patients. The significance of this case lies in its demonstration that the absence of autoimmune markers does not preclude a diagnosis of insulin-deficient diabetes requiring insulin therapy. The paper claims that early recognition of this subtype is essential to prevent the progression to DKA. Specifically, the authors conclude that clinicians should consider Type 1B diabetes in children presenting with severe hyperglycemia and normal C-peptide levels when autoimmune markers are absent, particularly if the patient shows a poor response to oral medications. The case underscores the need for flexible diagnostic thinking to ensure timely intervention and appropriate management.